Prostate cancer screening proven ineffective

30 June 2009 00:00 in Industry related health news


Prostate cancer screening has "yet to prove its worth", according to a new report.

The research found the benefit of screening - with the prostate?specific antigen (PSA) blood test - was "at best small".

Because the cancer is virtually ubiquitous in men as they age, the goal of finding more cancers is "not acceptable".

In related research, published in the CA: A Cancer Journal for Clinicians, it was found prostate cancer screening doubles the risk of lifetime diagnosis.

It discovered public health principles demand screening to reduce the risk of death from prostate cancer, reduce suffering and reduce health care costs when compared to non-screening.

However, the authors said screening had yet to meet one of these standards to date.

The researchers said: "Men should discuss the now quantifiable risks and benefits of having a PSA test with their physician and then share in making an informed decision.

"The weight of the decision should not be thrown into the patient's lap."

Other news stories from 30/06/2009

• UCB voices delight at Neupro availability
• Gilead pleased with CHMP recommendation
• Sanofi-Aventis says patient safety is important
• Hospira first to offer azithromycin drug delivery system
• Beiersdorf says it is pleased to launch new products
• Takeda submits extra Alogliptin applications
• Novo Nordisk discusses safety of insulin products
• Royal Canin welcomes new recruits
• Reckitt Benckiser competes during economic downturn
• Prostate cancer screening proven ineffective
• Bausch and Lomb launches information centre
• Inquest opens into girl's death from swine flu
• Calls for a tripling of dementia research funding
• Swine flu may have been leaked from laboratory
• Roche says it wants to think about ABPI relationship
• Covidien ranked number one innovator
• Medtronic accepts terms of preliminary injunction
• Bayer Schering Pharma to develop cancer-related targets
• AstraZeneca to pay milestone if Vimovo is approved
• Procter and Gamble advertisements feature sporting greats
• Church and Dwight says it is saddened by death of spokesperson
• Ceva Animal Health's product recommended to calm dogs
• Bayer Animal Health sponsors TV show
• The Body Shop comes top of recruitment site list
• Fort Dodge Animal Health says producers can have access to experts
• Public offered allergy screenings
• Pre-registration pharmacists to take part in pilot scheme
• Thermo Fisher Scientific solvent delivery systems said to bring flexibility
• Agilent Technologies says new oscilloscope probe positioners are stable and quick
• Mettler Toledo says balance range brings lasting value

Recent news

• Dechra launched CPD series on methadone
• GDC welcomes High Court ruling on illegal tooth whitening
• New study highlights obesity bias among trainee doctors
• Agilent agrees new biologic and vaccine analysis collaboration
• NHS staff 'do not believe care quality is prioritised enough'

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency

Feedback | News Archive | Browse News | Hotels | Links | Browse Jobs | Legal Notice | Privacy Policy

© Copyright 2013 Zenopa Ltd